Piramal Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0DK501011
  • NSEID: PPLPHARMA
  • BSEID: 543635
INR
208.80
-1.85 (-0.88%)
BSENSE

Sep 24, 02:48 PM

BSE+NSE Vol: 38.12 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "208.80",
    "chg": -1.85,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "210.65",
    "mcapval": "27,798.55 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0DK501011",
    "curr_date": "Sep 24, 02:48 PM",
    "curr_time": "14:49 PM",
    "last_traded_at": "Sep 24, 02:48 PM IST",
    "bse_nse_vol": "38.12 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4201796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4201796.png",
        "date": "2026-09-23 08:05:00",
        "description": "Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late September 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4200465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4200465.png",
        "date": "2026-09-22 08:07:51",
        "description": "Piramal Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, supported by key indicators such as MACD, Bollinger Bands, and moving averages. Despite some mixed signals on monthly charts, the stock’s recent price action and technical parameters suggest an improving outlook for this small-cap pharmaceutical player."
      },
      {
        "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-4199770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_mojoScore_4199770.png",
        "date": "2026-09-21 10:10:31",
        "description": "Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4194311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4194311.png",
        "date": "2026-09-16 08:09:42",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of mid-2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving technical landscape, key momentum indicators, and comparative performance against the broader Sensex benchmark."
      },
      {
        "title": "Piramal Pharma Ltd Falls 1.38%: 4 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-falls-138-4-key-factors-driving-the-weekly-move-4191195",
        "imagepath": "",
        "date": "2026-09-12 11:01:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> New 52-week high at Rs.221.85</p>\n                    <p><strong>8 Sep:</strong> All-time high reached at Rs.226.9 with exceptional volume surge</p>\n                    <p><strong>9 Sep:</strong> Sharp price correction amid market weakness</p>\n                    <p><strong>11 Sep:</strong> Week closes at Rs.211.25, down 1.38%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.219.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.211.25</div><div class=\"stat-change ne..."
      },
      {
        "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-4189305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_mojoScore_4189305.png",
        "date": "2026-09-10 10:10:03",
        "description": "Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-sees-exceptional-volume-surge-amid-bullish-momentum-4186742",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_most_active_equities_by_volume_4186742.png",
        "date": "2026-09-08 12:00:09",
        "description": "Piramal Pharma Ltd (PPLPHARMA) emerged as one of the most actively traded stocks on 8 September 2026, registering a remarkable volume surge that coincided with a notable price appreciation. Despite a broader market downturn, the pharmaceutical company outperformed its sector and benchmark indices, signalling heightened investor interest and potential accumulation."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Piramal Pharma Ltd to 52-Week High of Rs 226.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-hits-new-52-week-high-at-rs2269-4186485",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_priceRelatedfactors_4186485.png",
        "date": "2026-09-08 10:05:07",
        "description": "Surging past its previous peaks, Piramal Pharma Ltd touched a fresh 52-week high of Rs 226.9 on 8 Sep 2026, marking a significant milestone in its price momentum. This advance comes amid a broader market downturn, underscoring the stock's resilience and technical strength."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-market-volatility-4185768",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4185768.png",
        "date": "2026-09-08 08:08:57",
        "description": "Piramal Pharma Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by a combination of technical indicators including MACD, RSI, Bollinger Bands, and moving averages, signalling a potential uptrend despite mixed monthly signals and a challenging broader market environment."
      }
    ],
    "total": 501,
    "sid": "1003728",
    "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating -Niche Ninety",
      "datetime": "18-Sep-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA Inspection",
      "datetime": "14-Sep-2026",
      "details": "Please refer attached file",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Sep-2026",
      "details": "Please refer attached file",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views

Piramal Pharma Ltd Falls 1.38%: 4 Key Factors Driving the Weekly Move

2026-09-12 11:01:26

Key Events This Week

7 Sep: New 52-week high at Rs.221.85

8 Sep: All-time high reached at Rs.226.9 with exceptional volume surge

9 Sep: Sharp price correction amid market weakness

11 Sep: Week closes at Rs.211.25, down 1.38%

stock-recommendationAnnouncement

Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG Rating -Niche Ninety

18-Sep-2026 | Source : BSE

Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - FDA Inspection

14-Sep-2026 | Source : BSE

Please refer attached file

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Sep-2026 | Source : BSE

Please refer attached file

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Piramal Pharma Ltd has declared 1% dividend, ex-date: 16 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Piramal Pharma Ltd has announced 5:46 rights issue, ex-date: 02 Aug 23

Footer loading